Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-14 Sale |
2025-03-18 6:35 pm |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
79,146 | $12.9 | $1,021,211 | 174,306 (Direct) |
View |
2023-06-15 Sale |
2023-06-20 5:23 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,296 | $28.02 | $64,343 | 104,905 (Direct) |
View |
2023-06-02 Sale |
2023-06-06 7:41 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
7,500 | $24.82 | $186,136 | 221,975 (Direct) |
View |
2023-03-09 Sale |
2023-03-10 4:05 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
29,971 | $29.07 | $871,257 | 0 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 6:04 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
6,843 | $35.66 | $244,021 | 59,753 (Direct) |
View |
2022-12-20 Sale |
2022-12-22 4:42 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $29.15 | $493,398 | 105,768 (Direct) |
View |
2022-12-15 Sale |
2022-12-19 7:22 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $28.37 | $45,311 | 124,591 (Direct) |
View |
2022-12-12 Sale |
2022-12-14 8:56 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $28.12 | $457,077 | 142,144 (Direct) |
View |
2022-11-15 Sale |
2022-11-16 6:45 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $22.05 | $179,156 | 21,875 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-14 Exercise |
2025-03-18 6:35 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
79,146 | $5.45 | 174,306 (Direct) |
View |
2025-03-14 Exercise |
2025-03-18 6:35 pm |
N/A 2033-12-14 |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
78,966 | $0 | 174,306 (Direct) |
View |
Ownership |
2024-09-12 9:20 pm |
N/A 2033-12-14 |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
0 | $0 | 388,502 (Direct) |
View |
2023-06-15 Exercise |
2023-06-20 5:23 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,297 | $0 | 104,905 (Direct) |
View |
2023-06-15 Exercise |
2023-06-20 5:23 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,296 | $23.03 | 104,905 (Direct) |
View |
2023-06-05 Exercise |
2023-06-06 7:41 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
5,625 | $18.51 | 221,975 (Direct) |
View |
2023-06-02 Exercise |
2023-06-06 7:41 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
1,875 | $14 | 221,975 (Direct) |
View |
2023-06-02 Exercise |
2023-06-06 7:41 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
7,500 | $0 | 221,975 (Direct) |
View |
2023-02-08 Option Award |
2023-02-10 4:47 pm |
N/A 2033-02-08 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
108,000 | $0 | 108,000 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,872 | $14 | 59,753 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
6,843 | $0 | 59,753 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
4,971 | $23.03 | 59,753 (Direct) |
View |
2022-12-20 Exercise |
2022-12-22 4:42 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $0 | 105,768 (Direct) |
View |
2022-12-20 Exercise |
2022-12-22 4:42 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $23.03 | 105,768 (Direct) |
View |
2022-12-15 Exercise |
2022-12-19 7:22 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $0 | 124,591 (Direct) |
View |
2022-12-15 Exercise |
2022-12-19 7:22 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $23.03 | 124,591 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 8:56 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $0 | 142,144 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 8:56 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $23.03 | 142,144 (Direct) |
View |
2022-11-15 Exercise |
2022-11-16 6:45 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $14 | 21,875 (Direct) |
View |
2022-11-15 Exercise |
2022-11-16 6:45 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $0 | 21,875 (Direct) |
View |
2022-02-02 Option Award |
2022-02-03 6:12 pm |
N/A 2032-02-02 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2021-10-04 6:38 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
0 | $0 | 109,500 (Direct) |
View |